Remimazolam dosing: computer-controlled vs. manual
Part of Brain & nervous system, Heart & circulation clinical trials.
This trial compares two ways of giving the sedative remimazolam during brain bypass surgery. It looks at which method uses less medicine. If you are having this surgery, you may be able to join.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 19 years old or older.
- You are scheduled for a type of brain surgery called cerebrovascular bypass.
- You are generally healthy or have a mild to moderate health condition (ASA class 1, 2, or 3).
- You are not allergic to benzodiazepine medicines.
- You do not have sleep apnea or severe breathing problems.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a computerized dosing system for a sedation medicine called remimazolam during general anesthesia. It is for adults having planned surgery and aims to see if the computer-guided dosing is safe and effective.
This trial tests a new sedative called remimazolam for people having planned heart surgery with a heart-lung machine. It aims to see if it works well and is safe for keeping you asleep during the operation.
This trial tests a sedative called remimazolam besylate in patients who need a breathing tube and light sedation after non-cardiac surgery. The goal is to see if it works well and is safe.
This study uses brain scans to see how a new sedative called remimazolam affects the brain in healthy adults. It will help researchers understand the drug's effects and ensure it's safe.
This trial tests a sedative called remimazolam for people who need a high-risk ERCP procedure (a scope exam of the bile ducts). It is looking at whether remimazolam can provide safe and effective sedation for patients with serious health problems.
This trial tests if patients can safely control their own sedation during hip replacement surgery using a drug called remimazolam. The sedation is given through a patient-controlled pump, while spinal anesthesia keeps the surgical area numb.
Hear when a new Moyamoya Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.